MARKET

LFVN

LFVN

LifeVantage
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.36
-0.39
-3.32%
After Hours: 11.36 0 0.00% 16:00 10/28 EDT
OPEN
11.66
PREV CLOSE
11.75
HIGH
11.66
LOW
11.23
VOLUME
35.33K
TURNOVER
--
52 WEEK HIGH
17.25
52 WEEK LOW
7.75
MARKET CAP
161.79M
P/E (TTM)
14.44
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
LifeVantage to Announce First Quarter Fiscal Year 2021 Results on November 3, 2020
SALT LAKE CITY, Oct. 20, 2020 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its first quarter ended September 30, 2020, after the stock market closes on Tuesday, November 3, 2020. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. or international callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, November 10, 2020, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13711780, or (412) 317-6671 from international locations, and entering confirmation code 13711780.There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://public.viavid.com/index.php?id=141906. The webcast will be archived for approximately 30 days.About LifeVantage CorporationLifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product line, LifeVantage® Omega+ and ProBio dietary supplements, the TrueScience® line of Nrf2 infused skin care and hair care products, Petandim® for Dogs, Axio® smart energy drink mixes, and the PhysIQ™ weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.Investor Relations Contact:Scott Van Winkle Managing Director, ICR (617) 956-6736 scott.vanwinkle@icrinc.com
GlobeNewswire · 10/20 13:00
Here's Why I Think LifeVantage (NASDAQ:LFVN) Might Deserve Your Attention Today
Simply Wall St. · 10/09 15:45
LifeVantage Announces Management Transition
Steven Fife Appointed Interim Chief Executive Officer Justin Rose to Lead Combined Sales & Marketing TeamReiterates Fiscal 2021 GuidanceSALT LAKE CITY, Sept. 08, 2020 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that Darren Jensen, the Company's President and Chief Executive
GlobeNewswire · 09/08 20:05
Is LifeVantage Corporation's(NASDAQ:LFVN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Simply Wall St. · 09/03 15:46
LD Micro - 360 Companies - Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
ACCESSWIRE · 08/31 22:00
LifeVantage FQ4 earnings shows strength amid pandemic
LifeVantage ([[LFVN]] +1.0%) reports FQ4 revenue of $59.4M(+5.7% Y/Y)Revenue breakdown: America +5.9% Y/Y; Asia/Pacific & Europe +5.1%;Total active accounts increased 2.3% sequentially to 179,000.Gross profit was $49.9M, gross margin of 84.1%.SG&A was $14.8M vs. $15.3M prior.Adjusted
Seekingalpha · 08/19 16:03
LifeVantage Corporation (LFVN) CEO Darren Jensen on Q4 2020 Results - Earnings Call Transcript
LifeVantage Corporation (NASDAQ:LFVN) Q4 2020 Earnings Conference Call August 18, 2020 16:30 ET Company Participants Scott Van Winkle - Investor Relations Darren Jensen - Chief Executive Officer Steve Fife - Chief Financial Officer Conference Call Participants Doug Lane - Lane Research Presentation Operator Good day, ladies and gentlemen.
Seeking Alpha - Transcript · 08/19 02:12
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2020
GlobeNewswire · 08/18 21:05
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LFVN. Analyze the recent business situations of LifeVantage through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LFVN stock price target is 20.00 with a high estimate of 20.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 120
Institutional Holdings: 7.15M
% Owned: 50.21%
Shares Outstanding: 14.24M
TypeInstitutionsShares
Increased
33
413.68K
New
28
-13.25K
Decreased
21
266.02K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-2.08%
Pharmaceuticals & Medical Research
-2.11%
Key Executives
Chairman/Independent Director
Garry Mauro
President/Chief Executive Officer/Chief Financial Officer
Steven Fife
Chief Operating Officer
Charles Wach
Chief Marketing Officer/Director of Sales
Justin Rose
General Counsel
Kevin McMurray
Senior Vice President/Director of Human Resources
Michelle Oborn-Virchow
Independent Director
Michael Beindorff
Independent Director
Erin Brockovich
Independent Director
Raymond Greer
Independent Director
Vinayak Hegde
Independent Director
Darwin Lewis
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About LFVN
LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of LifeVantage Corp stock information, including NASDAQ:LFVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFVN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LFVN stock methods without spending real money on the virtual paper trading platform.